Search Result for 'advanced'

Sandia Labs shows machine learning could lop a year off technology design cycleCredit: Eric Lundin, Sandia National Laboratories ALBUQUERQUE, N.M. ...

Scientists explain how selective electrostatic doping can balance the charge in optoelectronic devices with 2D materialsCredit: DGIST 2D materials, consisting ...

Anal cancer is rare but growing in numbers; a new phase 3 trial for patients with metastatic disease aims to ...

Credit: Hanacek/NIST JILA researchers have used a state-of-the-art atomic clock to narrow the search for elusive dark matter, an example ...

Using analytical models to evaluate the reflection directional performance of the retro-reflective materials applied to building facadesCredit: COPYRIGHT (C) TOYOHASHI ...

Credit: Center for Global Discovery and Conservation Science at Arizona State University Nearly 75% of the world's coral reefs are ...

UC Riverside-led study describes first published survey documenting nature and extent of caregiver mistreatment of this populationCredit: Stan Lim, UC ...

Uppstroms incorporates personal and population-level social determinants of healthCredit: Regenstrief Institute INDIANAPOLIS -- Research scientists from Regenstrief Institute and Indiana ...

Researchers at Kanazawa University identified that SUCLA2-deficient prostate cancer cells can be selectively treated with thymoquinoneCredit: Kanazawa University Kanazawa, Japan ...

Credit: Photo by L. Brian Stauffer. CHAMPAIGN, Ill. -- Researchers working to maximize solar panel efficiency said layering advanced materials ...

Credit: University of California San Diego Patients receiving care for advanced cancer at Moores Cancer Center at UC San Diego ...

New technologies will analyze and archive data focused on the interplay between the human microbiome and diverse types of cancerCredit: ...

Credit: Andrew Sproles, ORNL/U.S. Department of Energy Scientists at Oak Ridge National Laboratory used new techniques to create a composite ...

Credit: Dana-Farber Cancer Institute BOSTON - An immunotherapy agent combined with a tyrosine kinase inhibitor drug significantly improved progression-free survival ...